1.800.979.8292

Benefits of Caris Registry Participation

Benefits to the Hematologist/Oncologist:

The primary advantage to participation in the registry is the opportunity to advance personalized medicine and improve patient outcomes. There are numerous other benefits to participation. Some are immediately recognized, while others develop over time.

  • Short-term advantages:
    • Identificaiton of candidates for clinical trials
    • The evolution of molecular diagnostics and targeted therapeutics
  • Long-term:
    • Data from registry will be used to publish new biomarker relationships to drive clinical decisionmaking.
    • Reports may be sufficient level of evidence for reimbursement approval for possibly utilizing an off-label drug
    • Results from queries submitted by the registry participants are used to advance medicine through publication.

Benefits to Patients

For some patients, the emotional reward gained from the knowledge that their disease information could eventually help another patient could be reason enough to be enrolled in the registry.

  • Short-term advantages:
    • Patients gain a chance to contribute to important scientific research.
  • Long-term advantages:
    • Patient data drives the evolution of more effective cancer and other therapies.
    • Patient data provides a means through which hematologists\oncologists can make evidence-based and data-driven decisions for future, patients.